Polar Asset Management Partners Inc. Macrogenics Inc Transaction History

Polar Asset Management Partners Inc.

  • $2.98 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.25 - $9.99 $314,100 - $1.39 Million
-139,600 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$15.91 - $21.88 $1.58 Million - $2.18 Million
99,600 Added 249.0%
139,600 $2.24 Million
Q2 2021

Aug 16, 2021
BUY
$20.49 - $35.63 $819,599 - $1.43 Million
40,000 New
40,000 $1.07 Million

Others Institutions Holding MGNX

# of Institutions
132
Shares Held
55.4M
Call Options Held
215K
Put Options Held
238K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $200M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email